CALiaGold ®

Sentinel CH. SpA

Milano, Italy

SENTINEL GROUP is a leading provider of in vitro diagnostic (IVD) assays, offering a comprehensive solution for various healthcare needs. The group comprises three specialized companies: SENTINEL DIAGNOSTICS , focused on developing and manufacturing Clinical Chemistry and Immunochemistry assays, offers a broad portfolio of kits compatible with the most advanced analytical platforms and distributed through established partners as well as with a network of committed, independent distributors. Additionally, Sentinel Diagnostics develops and delivers worldwide a panel of fecal assays, including the FOB Gold ® line for colorectal cancer screening and the CALiaGold ® line for fecal calprotectin quantification. Complementing these, in the field of Molecular Diagnostics, the innovative STAT-NAT ® line provides user-friendly and eco-conscious, high-quality virology and respiratory assays ( www.sentineldiagnostics.com ). EUREKA LAB DIVISION ( www.eurekakit.com ) has been operating in the IVD chromatographic market for 25 years, developing, producing and commercializing the world s largest range of ready-to-use diagnostic kits for various applications (HPLC, GC, GC-MS, LC-MS/MS) in specific areas like Special Clinical Chemistry, Therapeutic Drug Monitoring, Occupational and Forensic Toxicology while PRIMA LAB is dedicated to developing and providing a comprehensive range of professional and self-tests for various clinical applications ( https://primalabsa.ch ).